These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36018387)

  • 1. Equilibration rate constant, k
    Masui K; Hagihira S
    J Anesth; 2022 Dec; 36(6):757-762. PubMed ID: 36018387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population pharmacokinetic model of remimazolam for general anesthesia and consideration of remimazolam dose in clinical practice.
    Masui K; Stöhr T; Pesic M; Tonai T
    J Anesth; 2022 Aug; 36(4):493-505. PubMed ID: 35708787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correction: Equilibration rate constant, k
    Masui K; Hagihira S
    J Anesth; 2022 Dec; 36(6):763. PubMed ID: 36103090
    [No Abstract]   [Full Text] [Related]  

  • 4. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part II. Population pharmacokinetic and pharmacodynamic modeling and simulation.
    Wiltshire HR; Kilpatrick GJ; Tilbrook GS; Borkett KM
    Anesth Analg; 2012 Aug; 115(2):284-96. PubMed ID: 22253270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population pharmacokinetic/pharmacodynamic modeling for remimazolam in the induction and maintenance of general anesthesia in healthy subjects and in surgical subjects.
    Zhou J; Leonowens C; Ivaturi VD; Lohmer LL; Curd L; Ossig J; Schippers F; Petersen KU; Stoehr T; Schmith V
    J Clin Anesth; 2020 Nov; 66():109899. PubMed ID: 32585566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimation of the plasma effect site equilibration rate constant (ke0) of propofol in children using the time to peak effect: comparison with adults.
    Muñoz HR; Cortínez LI; Ibacache ME; Altermatt FR
    Anesthesiology; 2004 Dec; 101(6):1269-74. PubMed ID: 15564932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rocuronium pharmacodynamic models for published five pharmacokinetic models: age and sex are covariates in pharmacodynamic models.
    Masui K; Ishigaki S; Tomita A; Otake H
    J Anesth; 2018 Oct; 32(5):709-716. PubMed ID: 30099599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time-to-Event Modeling for Remimazolam for the Indication of Induction and Maintenance of General Anesthesia.
    Lohmer LL; Schippers F; Petersen KU; Stoehr T; Schmith VD
    J Clin Pharmacol; 2020 Apr; 60(4):505-514. PubMed ID: 31989598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Pharmacodynamics of Remimazolam (CNS 7056) after Continuous Infusion in Healthy Male Volunteers: Part I. Pharmacokinetics and Clinical Pharmacodynamics.
    Schüttler J; Eisenried A; Lerch M; Fechner J; Jeleazcov C; Ihmsen H
    Anesthesiology; 2020 Apr; 132(4):636-651. PubMed ID: 31972655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remimazolam - current knowledge on a new intravenous benzodiazepine anesthetic agent.
    Kim SH; Fechner J
    Korean J Anesthesiol; 2022 Aug; 75(4):307-315. PubMed ID: 35585830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychomotor Recovery Following Remimazolam-induced Sedation and the Effectiveness of Flumazenil as an Antidote.
    Chen X; Sang N; Song K; Zhong W; Wang H; Jiang J; Huang Y; Hu P
    Clin Ther; 2020 Apr; 42(4):614-624. PubMed ID: 32178858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial.
    Doi M; Hirata N; Suzuki T; Morisaki H; Morimatsu H; Sakamoto A
    J Anesth; 2020 Aug; 34(4):491-501. PubMed ID: 32303884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel technique to determine an 'apparent ke0 ' value for use with the Marsh pharmacokinetic model for propofol.
    Thomson AJ; Nimmo AF; Engbers FH; Glen JB
    Anaesthesia; 2014 May; 69(5):420-8. PubMed ID: 24738799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of the 95% effective dose of remimazolam to achieve loss of consciousness during anesthesia induction in different age groups.
    Oh J; Park SY; Lee SY; Song JY; Lee GY; Park JH; Joe HB
    Korean J Anesthesiol; 2022 Dec; 75(6):510-517. PubMed ID: 35912426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a modified propofol equilibration rate constant (k(e0)) on the effect-site concentration at loss and recovery of consciousness with the Marsh model.
    Seo JH; Goo EK; Song IA; Park SH; Park HP; Jeon YT; Hwang JW
    Anaesthesia; 2013 Dec; 68(12):1232-8. PubMed ID: 24032636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of the plasma effect site equilibration rate constant of sufentanil in children using the time to peak effect of heart rate and blood pressure.
    Song IK; Lee JH; Jung S; Kim JT; Kim HS
    Indian J Pharmacol; 2015; 47(4):360-4. PubMed ID: 26288466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting prolonged time to extubation in patients given remimazolam.
    Shimamoto Y; Sanuki M; Kurita S; Ueki M; Kuwahara Y; Matsumoto A
    PLoS One; 2022; 17(5):e0268568. PubMed ID: 35584094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of two Ke0 in the same pharmacokinetic propofol model: study on loss and recovery of consciousness.
    Simoni RF; Esteves LO; Miziara LE; Cangiani LM; Alves GG; Romano AL; Hansen PÚ; Vianna PT
    Rev Bras Anestesiol; 2011; 61(4):397-408. PubMed ID: 21724003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remimazolam: First Approval.
    Keam SJ
    Drugs; 2020 Apr; 80(6):625-633. PubMed ID: 32274703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of remimazolam compared with propofol in induction of general anesthesia.
    Dai G; Pei L; Duan F; Liao M; Zhang Y; Zhu M; Zhao Z; Zhang X
    Minerva Anestesiol; 2021 Oct; 87(10):1073-1079. PubMed ID: 34263581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.